Leustroducsin B activates nuclear factor-kB via the acidic sphingomyelinase pathway in human bone marrow-derived stromal cell line KM-102

Journal of Interferon and Cytokine Research

Volumn 22, Issue 3, 2002, Pages 343-350

  Koishi, Ryuta ^a   Yoshimura, Chigusa ^a   Kohama, Takafumi ^a   Serizawa, Nobufusa ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMPHOPHILE; DESIPRAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON INDUCING AGENT; INTERLEUKIN 11; INTERLEUKIN 6; INTERLEUKIN 8; LEUSTRODUSCIN B; LUCIFERASE; MESSENGER RNA; PERHEXILINE MALEATE; SPHINGOMYELIN PHOSPHODIESTERASE; TRANSCRIPTION FACTOR AP 1; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIOXIDANT; BRIDGED COMPOUND; DRUG DERIVATIVE; LACTONE; LEUSTRODUCSIN B; ORGANOPHOSPHORUS COMPOUND; PERHEXILINE; PHOSPHODIESTERASE INHIBITOR; THIOKETONE; TRICYCLODECANE 9 YL XANTHOGENATE; TRICYCLODECANE-9-YL-XANTHOGENATE;

ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA FLANKING REGION; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; PLASMID; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SIGNAL TRANSDUCTION; STROMA CELL; TRANSCRIPTION INITIATION; BIOSYNTHESIS; CELL CLONE; CELL LINE; CYTOLOGY; GENETICS; METABOLISM; PROTEIN PROCESSING; SITE DIRECTED MUTAGENESIS; TRANSACTIVATION;

ACETYLCYSTEINE; ANTIOXIDANTS; BONE MARROW CELLS; BRIDGED COMPOUNDS; CELL LINE; CLONE CELLS; DESIPRAMINE; GENES, REPORTER; HUMAN; INTERLEUKIN-11; INTERLEUKIN-8; LACTONES; MUTAGENESIS, SITE-DIRECTED; NF-KAPPA B; ORGANOPHOSPHORUS COMPOUNDS; PERHEXILINE; PHOSPHODIESTERASE INHIBITORS; POINT MUTATION; PROMOTER REGIONS (GENETICS); PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; SPHINGOMYELIN PHOSPHODIESTERASE; STROMAL CELLS; THIONES; TRANS-ACTIVATION (GENETICS); HUMANS;

STREPTOMYCES; STREPTOMYCES PLATENSIS;

EID: 0036013763     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999002753675776     Document Type: Article

References (42)

1. The sphingomyelin cycle and the second messenger function of ceramide
2. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling
3. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor α γ-interferon
4. Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1β
5. Characterization of a ceramide-activated protein kinase: Stimulation by tumor necrosis factor α
6. Tumor necrosis factor-α activates the sphinogomyelin signal transduction pathway in a cell-free system
7. Ceramide signaling and immune response
8. Sphingomyelinases
9. Introduction: Sphingolipids and their metabolites in cell regulation
10. Functional dichtomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling
11. Renaturation and tumor necrosis factor-alpha stimulation of a 97-kDa ceramide-activated protein kinase
12. Tumor necrosis factor-induced activation and increased tyrosine phosphorylation of mitogen-activated protein (MAP) kinase in human fibroblasts
13. The stress-activated protein kinase subfamily of c-Jun kinases
14. TNF activates NF-kB by phosphatidylcholine-specific phospholipase c-induced "acidic" sphingomyelin breakdown
15. Tumor necrosis factor-alpha (TNF-alpha) signal transduction through ceramide. Dissociation of growth inhibitory effects of TNF-alpha from activation of nuclear factor-kappa B
16. Selective involvement of ceramide in cytokine-induced apoptosis. Ceramide inhibits phorbol ester activation of nuclear factor kappa B
17. Dissociation of endogenous cellular ceramide from NF-kappa B activation
18. Acid sphingomyelinase is not essential for the IL-1 and tumor necrosis factor receptor signaling pathway leading to NK-kB activation
19. Ceramide activates the stress-activated protein kinases
20. Novel microbial metabolites of the phoslactomycins family induce production of colony-stimulating factors by bone marrow stromal cells. I. Taxonomy, fermentation and biological properties
21. Novel microbial metabolites of the phoslactomycins family induce production of colony-stimulating factors by bone marrow stromal cells. II. Isolation, physico-chemical properties and structure determination
22. Augmentation of host resistance against bacterial infection by treatment with leustroducsin B, a new CSF inducer
23. The effect of leustroducsin B on the production of cytokines by human mesenchymal cells
24. Leustroducsin B, a new cytokine inducer derived from an actinomycetes, induces thrombocytosis in mice
25. Generation of functional clonal cell lines from human bone marrow stroma
26. Genome structure of the human monocyte-derived neutrophill chemotactic factor IL-8
27. Molecular cloning of cDNA encoding adipogenesis inhibitory factor and identity with IL-11
28. Genome sequence and chromosomal location of human interleukin-11 gene
29. Cloning and characterization of a novel oxidoreductase KDRF from a human bone marrow-derived stromal cell line KM-102
30. Reactive oxigen intermediates as apparently widely used messengers in the activation of the NF-kB transcription factor and HIV-1
31. Dithiocarbamates as potent inhibitors of nuclear factor kB activation in intact cells
32. 2 and antioxidants have opposite effects on activation of NF-kB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor
33. Inhibition of HIV-1 replication and NF-kB activity by cysteine and cysteine derivatives
34. Lipid and lysosomal enzymes in human fibroblasts cultured with perhexiline maleate
35. Evidence against involvement of the acid lysosomal sphingomyelinas e in the tumor-necrosis-factor- and interleukin-1-induced sphingomyelin cycle and cell proliferation in human fibroblasts
36. The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts
37. Regulation of interleukin (IL)-11 gene expression in IL-1 induced primate bone marrow stromal cells
38. Characterization of a functional NF-kB site in the human interleukin 1b promoter: Evidence for a positive autoregulation loop
39. The inducible transcription activator NF-kB: Regulation by distinct protein subunits
40. Tumor necrosis factor receptor-mediated signaling pathways
41. Differential effects of sphingomyelin hydrolysis and resynthesis on the activation of NF-kB in normal and SV40-transformed human fibroblasts